Cargando…

Liver regeneration biology: Implications for liver tumour therapies

The liver has remarkable regenerative potential, with the capacity to regenerate after 75% hepatectomy in humans and up to 90% hepatectomy in some rodent models, enabling it to meet the challenge of diverse injury types, including physical trauma, infection, inflammatory processes, direct toxicity,...

Descripción completa

Detalles Bibliográficos
Autores principales: Hadjittofi, Christopher, Feretis, Michael, Martin, Jack, Harper, Simon, Huguet, Emmanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716989/
https://www.ncbi.nlm.nih.gov/pubmed/35070734
http://dx.doi.org/10.5306/wjco.v12.i12.1101
_version_ 1784624439509385216
author Hadjittofi, Christopher
Feretis, Michael
Martin, Jack
Harper, Simon
Huguet, Emmanuel
author_facet Hadjittofi, Christopher
Feretis, Michael
Martin, Jack
Harper, Simon
Huguet, Emmanuel
author_sort Hadjittofi, Christopher
collection PubMed
description The liver has remarkable regenerative potential, with the capacity to regenerate after 75% hepatectomy in humans and up to 90% hepatectomy in some rodent models, enabling it to meet the challenge of diverse injury types, including physical trauma, infection, inflammatory processes, direct toxicity, and immunological insults. Current understanding of liver regeneration is based largely on animal research, historically in large animals, and more recently in rodents and zebrafish, which provide powerful genetic manipulation experimental tools. Whilst immensely valuable, these models have limitations in extrapolation to the human situation. In vitro models have evolved from 2-dimensional culture to complex 3 dimensional organoids, but also have shortcomings in replicating the complex hepatic micro-anatomical and physiological milieu. The process of liver regeneration is only partially understood and characterized by layers of complexity. Liver regeneration is triggered and controlled by a multitude of mitogens acting in autocrine, paracrine, and endocrine ways, with much redundancy and cross-talk between biochemical pathways. The regenerative response is variable, involving both hypertrophy and true proliferative hyperplasia, which is itself variable, including both cellular phenotypic fidelity and cellular trans-differentiation, according to the type of injury. Complex interactions occur between parenchymal and non-parenchymal cells, and regeneration is affected by the status of the liver parenchyma, with differences between healthy and diseased liver. Finally, the process of termination of liver regeneration is even less well understood than its triggers. The complexity of liver regeneration biology combined with limited understanding has restricted specific clinical interventions to enhance liver regeneration. Moreover, manipulating the fundamental biochemical pathways involved would require cautious assessment, for fear of unintended consequences. Nevertheless, current knowledge provides guiding principles for strategies to optimise liver regeneration potential.
format Online
Article
Text
id pubmed-8716989
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-87169892022-01-20 Liver regeneration biology: Implications for liver tumour therapies Hadjittofi, Christopher Feretis, Michael Martin, Jack Harper, Simon Huguet, Emmanuel World J Clin Oncol Review The liver has remarkable regenerative potential, with the capacity to regenerate after 75% hepatectomy in humans and up to 90% hepatectomy in some rodent models, enabling it to meet the challenge of diverse injury types, including physical trauma, infection, inflammatory processes, direct toxicity, and immunological insults. Current understanding of liver regeneration is based largely on animal research, historically in large animals, and more recently in rodents and zebrafish, which provide powerful genetic manipulation experimental tools. Whilst immensely valuable, these models have limitations in extrapolation to the human situation. In vitro models have evolved from 2-dimensional culture to complex 3 dimensional organoids, but also have shortcomings in replicating the complex hepatic micro-anatomical and physiological milieu. The process of liver regeneration is only partially understood and characterized by layers of complexity. Liver regeneration is triggered and controlled by a multitude of mitogens acting in autocrine, paracrine, and endocrine ways, with much redundancy and cross-talk between biochemical pathways. The regenerative response is variable, involving both hypertrophy and true proliferative hyperplasia, which is itself variable, including both cellular phenotypic fidelity and cellular trans-differentiation, according to the type of injury. Complex interactions occur between parenchymal and non-parenchymal cells, and regeneration is affected by the status of the liver parenchyma, with differences between healthy and diseased liver. Finally, the process of termination of liver regeneration is even less well understood than its triggers. The complexity of liver regeneration biology combined with limited understanding has restricted specific clinical interventions to enhance liver regeneration. Moreover, manipulating the fundamental biochemical pathways involved would require cautious assessment, for fear of unintended consequences. Nevertheless, current knowledge provides guiding principles for strategies to optimise liver regeneration potential. Baishideng Publishing Group Inc 2021-12-24 2021-12-24 /pmc/articles/PMC8716989/ /pubmed/35070734 http://dx.doi.org/10.5306/wjco.v12.i12.1101 Text en ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Review
Hadjittofi, Christopher
Feretis, Michael
Martin, Jack
Harper, Simon
Huguet, Emmanuel
Liver regeneration biology: Implications for liver tumour therapies
title Liver regeneration biology: Implications for liver tumour therapies
title_full Liver regeneration biology: Implications for liver tumour therapies
title_fullStr Liver regeneration biology: Implications for liver tumour therapies
title_full_unstemmed Liver regeneration biology: Implications for liver tumour therapies
title_short Liver regeneration biology: Implications for liver tumour therapies
title_sort liver regeneration biology: implications for liver tumour therapies
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716989/
https://www.ncbi.nlm.nih.gov/pubmed/35070734
http://dx.doi.org/10.5306/wjco.v12.i12.1101
work_keys_str_mv AT hadjittofichristopher liverregenerationbiologyimplicationsforlivertumourtherapies
AT feretismichael liverregenerationbiologyimplicationsforlivertumourtherapies
AT martinjack liverregenerationbiologyimplicationsforlivertumourtherapies
AT harpersimon liverregenerationbiologyimplicationsforlivertumourtherapies
AT huguetemmanuel liverregenerationbiologyimplicationsforlivertumourtherapies